RHPS has just mentioned the above in an e-mail, they have gone up 240% today - started at 0.60 and finished up at 1.65. Look to be quite interesting.

Thats not what I heard tabs.......

4 bottles of wine and a Snake Charmer springs to mind.

Nah....tabs doesn't blow and suck on pipes......tone deff.,.

Baleryou always were troublemixing with that bow-legged Tour de Force Cyclist too longhow he sits on that saddle?..(_!_) Anywayon a more sensible notelets hope the SP climbs to 5p tomorrowand you all get out with shed loads.......................
perhaps that wasnt too sensible a note?but its the best I can do before I fall overgood luck tomorahhhhhhhhhh!

I might be a plumber?

lol....are you celebrating on a good day trading, or is this just another day??

tabasco - only 4 bottles of vino - taking it easy today then! enjoy dude

Baleras you knowI laugh my way through life.it was just another manic dayfunnily enough the wife thought I had made a lot of dough?

Gibby4 bottlesI wish!

3 monkiesIm a charmerand not a snake.the very best of luck todaymay your wallet be as large as your smile

Cheers tabasco, same to you.

Something has been leaked?

Hope it leaks a lot more, in the right direction.

BUY SAR THE NEWS SHOWS IT IS GOING TO ROCKET

3m

More like a big ramp going on don't get sucked in.

No insider knowledge there then!

yeeeeeeeeeeeeeeeeeeehaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa

great rns - gonna end the day over 3p!!!!!

Sareum report positive tests on cancer drugs
StockMarketWire.com
Sareum, the specialist cancer drug discovery business, has announced positive results from pre-clinical in-vivo efficacy studies from their joint research collaboration with Cancer Research Technology and The Institute of Cancer Research.

A recent colon cancer pre-clinical model study carried out demonstrates that the combination of a collaboration Chk1 inhibitor, dosed via the oral route, in combination with a chemotherapeutic, gemcitabine, demonstrates a greater than two-fold reduction in cancer growth rate compared to treatment with the same dose of gemcitabine without the Chk1 inhibitor.

Sareum's CEO, Dr Tim Mitchell, commented: "These are exciting advances, demonstrating efficacy of our Chk1 compounds in several cancer models. Studies on additional models are on-going. We believe the results from the recently conducted studies will significantly enhance the licencing package and assist the collaboration in selecting the best compound for development into a clinical trials candidate".

Taken a punt in this, pure gamble....not sure at all....but will be patient (no pun), until decent profit emerges.....

Could easily go to 5p......volatile....

Kudos to Gibby who quite accurately predicted the SP finishing over 3p today :p

Well done all those in at low levels
D

Small profit showing......will this turn out to be a star ?.....could go much further on monday !...

3m's your luck might be in......keep watching.